Company profile: Beacon Discovery
1.1 - Company Overview
Company description
- Provider of GPCR-focused drug discovery services from concept to clinic, including over 8,000 assays, target identification, hit finding, lead optimization, mechanistic studies, and preclinical safety and toxicity. Offerings include small molecule support, LeadHunter cell-based assays for GPCRs and orphan GPCRs, phenotypic drug discovery, in vitro safety assays and panels, and ADME assays.
Products and services
- LeadHunter: Off-the-shelf, functional cell-based assay products for challenging targets, offering a portfolio of assays for GPCR targets and orphan GPCRs supporting functional characterization
- Drug Discovery Services: Comprehensive, GPCR-focused drug discovery services delivering over 8,000 assays, target identification, hit finding, lead optimization, mechanistic studies, and preclinical safety and toxicity assessments
- Phenotypic Drug Discovery: Translationally relevant biomarker-driven services that use biomarkers to deliver insights on mechanism of action, efficacy, and toxicity assessments for phenotypic discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Beacon Discovery
A4Cell
HQ: Spain
Website
- Description: Provider of SPAchip technology using intracellular silicon microchips to monitor living single cells and cellular pathways in real time without affecting viability. Offers kits: CytoCHECK pH Green, pH Red, Calcium; CytoTRACK pH Dual-Detection; and SpheroCHECK pH Green for 3D spheroids, enabling precise single-cell physiology monitoring to improve cell study data for understanding disease behavior.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A4Cell company profile →
Protedyne
HQ: United States
Website
- Description: Provider of laboratory automation systems that integrate powerful laboratory robotic hardware and industrial automation design principles, bringing serious laboratory automation to LabCorp's diagnostic testing facilities nationwide and supporting existing pharmaceutical, biotech, and diagnostic testing customers as a wholly owned subsidiary of Laboratory Corporation of America.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protedyne company profile →
M2P Labs
HQ: Germany
Website
- Description: Provider of microbioreactor and biochemical engineering solutions, including the BioLector high-throughput microbioreactor for microliter-scale fermentation with online monitoring (biomass, pH, dissolved oxygen, fluorescence); the RoboLector automated cultivation platform with liquid handling; and the FlowerPlate microtiter plate for enhanced oxygen transfer, plus technical/application support, demos, installation, and maintenance contracts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full M2P Labs company profile →
GlycoFi
HQ: United States
Website
- Description: Provider of biotherapeutic development based on glycan optimization technology and a yeast-based glycosylation protein manufacturing process, aiming to build its own pipeline of therapeutic proteins and partner with other drug-makers to develop products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlycoFi company profile →
Newport Labs
HQ: United States
Website
- Description: Provider of veterinary healthcare services and high-quality autogenous biologics for the livestock industry, applying 21st technology to a traditional autogenous approach to formulate products that pinpoint specific disease problems, supported by dedicated employees and innovative solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newport Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Beacon Discovery
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Beacon Discovery
2.2 - Growth funds investing in similar companies to Beacon Discovery
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Beacon Discovery
4.2 - Public trading comparable groups for Beacon Discovery
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →